Home › Answers › Fenbendazole

Does fenbendazole (the dog dewormer) work against cancer?

By the Cancer Clues team · Last updated 1 November 2026 · How our grades work

Here because of a specific diagnosis? This topic appears in our guides to: Lung Cancer · Prostate Cancer

What it is — and where the story comes from

Fenbendazole is a veterinary de-worming drug (for dogs, horses and livestock) from the benzimidazole family. In 2019, an American businessman named Joe Tippens went viral with the story that it had cured his advanced lung cancer. Here is the part the viral posts leave out: during the same period, Tippens was enrolled in a clinical trial receiving a then-cutting-edge treatment [9]. When two things happen at once, a story cannot tell you which one worked — or whether it was the combination, or luck. That is precisely why medicine runs trials.

What the evidence says

• The lab work is real. A 2018 study showed fenbendazole destabilizes the internal skeleton of cancer cells and kills them in dishes and in mice [1]. Hundreds of compounds clear that bar every year; most fail in humans.
• No human trial has ever been run. Not one, anywhere, of any size [2]. Reviews also note that swallowed fenbendazole may not even reach tumor-active levels in human blood [3].
• The one “positive” human paper was retracted. A three-patient case series claiming remissions was withdrawn by the journal in 2026 — it still circulates on social media as “proof” [6].
• The professional verdict: in 2026 the American Society of Clinical Oncology — the world's main organization of cancer doctors — formally recommended against fenbendazole (and ivermectin) for cancer outside clinical trials, citing the absence of any robust clinical evidence [2].
• Use is widespread and hidden. In a Korean survey after the story went viral, about half of cancer patients using de-wormers took them during chemotherapy — and 96.5% never told their doctors [7]. U.S. prescription data show use jumped again after a celebrity podcast in 2025 [9].

What patients report

Online groups contain thousands of hopeful reports — and we understand exactly why. Almost all involve people also receiving conventional treatment, which makes individual stories impossible to interpret, honestly, in either direction. What the published record adds is sobering: the documented human outcomes so far are liver injuries [4][5]. If you have real-world experience with fenbendazole — any outcome — we want to record it properly: .

Safety and interactions

• Fenbendazole is not approved for human use anywhere — there is no human dosing, purity, or safety standard. “Protocols” circulating online are guesses.
• Published liver injuries: a lung-cancer patient developed drug-induced liver injury after following the social-media protocol [4]; a prostate-cancer patient suffered severe liver injury after three months of fenbendazole plus ivermectin [5].
• A treatment-confusing trap: fenbendazole liver injury can look exactly like an immunotherapy side effect — doctors may pause your real treatment to chase it [4].
• Sellers marketing fenbendazole for cancer have received FDA warning letters [8].

If you're considering it anyway

We won't lecture you — we'll just be straight. Never let it replace or delay real treatment: that is the one way this story reliably ends badly. Tell your oncology team (they have seen it many times and their job is your safety, not judgment). Watch for liver warning signs — dark urine, yellowing eyes, deep fatigue — and know that no one can tell you a safe dose, because none has ever been established. If you want to support actual progress, ask us about clinical trials for your cancer type instead: we help people find them.

Common questions